Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000321971 | SCV000336095 | benign | not specified | 2015-10-13 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000343325 | SCV000383341 | likely benign | Charlevoix-Saguenay spastic ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000474698 | SCV000562830 | benign | Spastic paraplegia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000321971 | SCV001474670 | benign | not specified | 2019-11-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676362 | SCV001857213 | benign | not provided | 2018-10-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676362 | SCV005219352 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676362 | SCV000802138 | benign | not provided | 2017-06-13 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000343325 | SCV001463601 | benign | Charlevoix-Saguenay spastic ataxia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000321971 | SCV001958021 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000321971 | SCV001972546 | benign | not specified | no assertion criteria provided | clinical testing |